Cognition Therapeutics CMO Anthony Caggiano Withholds 4,680 Shares

What Happened

• Anthony Caggiano, Chief Medical Officer of Cognition Therapeutics (CGTX), had 4,680 shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units. The shares were valued at $1.12 each, for a total of approximately $5,242. This was a tax-withholding/cashless disposition rather than an open-market sale.

Key Details

• Transaction date: 2026-02-15; Form 4 filed: 2026-02-18 (appears to be filed within the normal reporting window).
• Price per share: $1.12; Shares withheld/disposed: 4,680; Total value: ~$5,242.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — the shares were withheld by the issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Transaction code: F (tax withholding/share withholding).

Context

• This is an administrative tax-withholding event tied to RSU vesting, not a sale into the market — it does not necessarily indicate a change in the insider’s view of the company. Such withholdings are common when equity awards vest and are generally routine.